Copyright
©The Author(s) 2005.
World J Gastroenterol. Oct 7, 2005; 11(37): 5828-5833
Published online Oct 7, 2005. doi: 10.3748/wjg.v11.i37.5828
Published online Oct 7, 2005. doi: 10.3748/wjg.v11.i37.5828
Table 1 Questionnaire on NSAID/ASA use
Use of NSAID/ASA | Yes/no |
If yes, which drug:............................ | |
- What dose……………………… | |
- How long……………………….. | |
Indication for NSAID/ASA…………....... | |
Indication for colonoscopy…………….. |
Table 2 Answers to the questionnaire in Table 1
n | % | |
NSAID | 326 | 58.3 |
ASA | 122 | 20.0 |
NSAID/ASA | 48 | 7.8 |
Table 3 Duration of ingestion of NSAID/ASA (%)
D | 4.6 |
Wk | 13.9 |
Mo | 21.5 |
Yr | 43.9 |
No information | 16.1 |
Table 4 Indication for use of NSAID/ASA (%)
Pain | 64.3 |
Polyarthritis | 12.3 |
Coronary heart disease | 10.2 |
Peripheral occlusive arterial disease | 7.9 |
Others | 5.7 |
Table 5 Indications for colonoscopy (%)
Melena | 23.9 |
Positive occult blood test | 11.0 |
Anemia | 21.6 |
Diarrhea | 19.4 |
Abdominal pain | 17.7 |
Weight loss | 1.9 |
Ileus or subileus | 1.1 |
Others | 1.1 |
Table 6 Frequency distribution of used NSAID preparations (%)
Diclofenac | 70.5 |
Ibuprofen | 7.3 |
Piroxicam | 1.4 |
Ketoprofen | 0.4 |
Phenylbutazone | 0.2 |
Combinations | 17.6 |
Table 7 Localization of the lesions (%)
Ileum | 4.5 |
Bauhin’s valve | 21.3 |
Cecum | 14.8 |
Ascending colon | 19.1 |
Right flexure | 7 |
Transverse colon | 15.7 |
Left flexure | 2.8 |
Descending colon | 6.7 |
Sigmoid colon | 5.3 |
Rectum | 2.8 |
Table 8 Frequency of lesion type (solitary and multiple lesions)
Solitary | Multiple | |
(n = 207) | (n = 319) | |
(%) | (%) | |
Erosions | 63.3 | 21.3 |
Ulcers | 21.7 | 56.4 |
Erosions+ulcers | 0 | 12.2 |
Regenerative mucosa | 15 | 10.1 |
Strictures | 11.1 | 18.8 |
Diaphragms | 1.0 | 4.4 |
Table 9 Age and sex distribution, location of lesions in right colon, and histological findings in the four groups of patients
n | F:M | Age (yr) | Locationright colon | Endoscopicsolitary lesion | Endoscopicmultiple lesions | Endoscopicstricture | Endoscopicdiaphragm | |
356 | 251:105 | 63±35 | 71.2% | 36.80% | 63.2% | 15.40% | 3.6% | |
NSAID | 58.3% | 2.4:1 | 28-98 | n = 131 | n = 225 | n = 55 | n = 13 | |
122 | 75:47 | 56.5±33.5 | 76.8% | 50% | 50% | 12.30% | 0.8% | |
ASA | 20% | 1.6:1 | 23-90 | n = 61 | n = 61 | n = 15 | n = 1 | |
48 | 39:9 | 68±21 | 80.8% | 31.2% | 68.8% | 25% | 2.10% | |
NSAID+ASA | 7.8% | 4.3:1 | 47-89 | n = 15 | n = 33 | n = 12 | n = 1 | |
85 | 50:35 | 54.5±35.5 | 75.60% | 68% | 31.8% | 8.20% | 1.2% | |
No NSAID/ASA | 13.9% | 1.4:1 | 19-90 | n = 58 | n = 27 | n = 7 | n = 1 |
Table 10 Frequency of histological findings in the four groups of patient
Solitaryerosion | Solitaryulcer | Solitaryregenerativemucosa | Multipleerosions | Multipleulcers | Multipleerosions+ulcers | Multipleregenerativemucosa | |
NSAID (%) | 23.7 | 76.3 | 13 | 36.5 | 46.6 | 10.8 | 6.1 |
n = 27 | n = 8 | n = 17 | n = 101 | n = 129 | n = 30 | n = 17 | |
ASA (%) | 26.2 | 55.7 | 14.8 | 26.2 | 51 | 9.7 | 13.1 |
n = 16 | n = 34 | n = 9 | n = 16 | n = 32 | n = 6 | n = 8 | |
NSAID+ASA(%) | 26.6 | 66.6 | 6.8 | 21.2 | 57.6 | 15.2 | 6 |
n = 4 | n = 10 | n = 1 | n = 7 | n = 19 | n = 5 | n = 2 | |
No | 27.6 | 65.6 | 3.4 | 25.9 | 59.3 | 3.7 | 11.1 |
No NSAID/ASA | |||||||
(%) | n = 16 | n = 38 | n = 2 | n = 7 | n = 16 | n = 1 | n = 3 |
- Citation: Stolte M, Karimi D, Vieth M, Volkholz H, Dirschmid K, Rappel S, Bethke B. Strictures, diaphragms, erosions or ulcerations of ischemic type in the colon should always prompt consideration of nonsteroidal anti-inflammatory drug-induced lesions. World J Gastroenterol 2005; 11(37): 5828-5833
- URL: https://www.wjgnet.com/1007-9327/full/v11/i37/5828.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i37.5828